The purpose of this study was to reexamine the Margolis and Heller (1987) normative tympanometric data (also American Speech-Language-Hearing [ASHA], 1990 interim norms) using a strict control over subject age and gender. Normative values for peak, compensated static acoustic admittance (Peak Ytm), acoustic equivalent volume (Vea), and tympanometric width (TW) were determined for 102 young adults with normal hearing. Relative to the Margolis and Heller normative values, significant differences were found for Vea and TW. Although statistically significant, these differences were small and of little clinical importance. However, significant and clinically important gender differences in young adults were observed for each of the tympanometric measures. Compared to males, females had lower Peak Ytm values, smaller Vea values, and higher TW values.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1044/1059-0889(1998/014) | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Effect of Deutetrabenazine on Chorea Among Patients With Huntington Disease: A Randomized Clinical Trial.
JAMA
July 2016
Harvard University, Boston, Massachusetts.
Importance: Deutetrabenazine is a novel molecule containing deuterium, which attenuates CYP2D6 metabolism and increases active metabolite half-lives and may therefore lead to stable systemic exposure while preserving key pharmacological activity.
Objective: To evaluate efficacy and safety of deutetrabenazine treatment to control chorea associated with Huntington disease.
Design, Setting, And Participants: Ninety ambulatory adults diagnosed with manifest Huntington disease and a baseline total maximal chorea score of 8 or higher (range, 0-28; lower score indicates less chorea) were enrolled from August 2013 to August 2014 and randomized to receive deutetrabenazine (n = 45) or placebo (n = 45) in a double-blind fashion at 34 Huntington Study Group sites.
Serious Asthma Events with Fluticasone plus Salmeterol versus Fluticasone Alone.
N Engl J Med
May 2016
From Respiratory Clinical Development (D.A.S., I.H.R., A.M.Y., C.M.P., K.S.B., S.J.P.) and Research and Development, Clinical Platforms and Sciences, Clinical Statistics (K.M.K., A.H.E.), GlaxoSmithKline, Durham, NC.
Background: The safe and appropriate use of long-acting beta-agonists (LABAs) for the treatment of asthma has been widely debated. In two large clinical trials, investigators found a potential risk of serious asthma-related events associated with LABAs. This study was designed to evaluate the risk of administering the LABA salmeterol in combination with an inhaled glucocorticoid, fluticasone propionate.
View Article and Find Full Text PDFThe purpose of this study was to reexamine the Margolis and Heller (1987) normative tympanometric data (also American Speech-Language-Hearing [ASHA], 1990 interim norms) using a strict control over subject age and gender. Normative values for peak, compensated static acoustic admittance (Peak Ytm), acoustic equivalent volume (Vea), and tympanometric width (TW) were determined for 102 young adults with normal hearing. Relative to the Margolis and Heller normative values, significant differences were found for Vea and TW.
View Article and Find Full Text PDFTympanograms were obtained from normal preschool and adult subjects with a prototype hand-held tympanometer to obtain normative values for four tympanometric variables: static admittance, equivalent ear canal volume, tympanometric peak pressure, and gradient. Effects of age group, sex, and pump speed (200 or 400 daPa/s) were determined. The results were incorporated into a four-part screening protocol (history, visual inspection, audiometry, and tympanometry) designed to reduce the excessive error rates associated with screening strategies that rely exclusively on tympanometry.
View Article and Find Full Text PDFWant AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!